(Q35594818)

9 August 2017

1 reference

title

Caught in the act: alpha-synuclein is the culprit in Parkinson's disease (English)

1 reference

9 August 2017

1 reference

1 reference

3

1 reference

9 August 2017

Jason L Eriksen

1

0 references

Leonard Petrucelli

series ordinal

4

object named as

Leonard Petrucelli

1 reference

9 August 2017

2

Ted M Dawson

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

40

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

453-456

1 reference

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Impairment of the ubiquitin-proteasome system by protein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Degradation of alpha-synuclein by proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Chaperoning brain degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Rare genetic mutations shed light on the pathogenesis of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

'Unfolding' pathways in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Neuropathology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Are ubiquitination pathways central to Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Ubiquitin-dependent protein degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

A transgenic mouse model of the ubiquitin/proteasome system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

The role of alpha-synuclein in Parkinson's disease: insights from animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Altered proteasomal function in sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900684-6

7 January 2021

10.1016/S0896-6273(03)00684-6

Identifiers

DOI

1 reference

9 August 2017

1 reference